IPP Bureau
SeQuent Scientific appoints Rajaram Narayanan as MD & CEO
By IPP Bureau - January 17, 2022
Narayanan to lead SeQuent through next phase of consolidation and growth
Strides receives USFDA approval for influenza medicine
By IPP Bureau - January 17, 2022
The company has 271 cumulative ANDA filings with USFDA of which 243 ANDAs have been approved and 28 are pending approval
WHO recommends two new drugs for COVID-19
By IPP Bureau - January 14, 2022
Their strong recommendation is based on moderate certainty evidence that it improves survival and reduces the need for ventilation
AIIMS now uses ImmersiveTouch for surgeries
By IPP Bureau - January 14, 2022
Chicago based virtual reality company reaches AIIMS, assisting in surgical planning and training
U.S. FDA approves treatment to control pain in cats with osteoarthritis
By IPP Bureau - January 14, 2022
It is the first monoclonal antibody drug for use in any animal species
Piramal Pharma Solutions adds roller compactor at Sellersville site
By IPP Bureau - January 14, 2022
Market data indicates that more than twenty percent of the new chemical entities being developed use roller compaction technology in their development and commercialization
Glenmark receives U.S. FDA approval for Ryaltris
By IPP Bureau - January 14, 2022
The recommended daily dose for Ryaltris is 2 sprays in each nostril twice daily
Evonik to build production plant for rhamnolipids in Slovakia
By IPP Bureau - January 14, 2022
The new plant at Slovenská ?up?a site in Slovakia is scheduled to come on stream in two years
LumiraDx Lab Covid-19 Antigen test detects the Omicron variant
By IPP Bureau - January 14, 2022
In-house wet testing with live Omicron virus demonstrated that the Antigen test detects the Omicron variant with comparable sensitivity to other variants
Hekka Labs introduces decentralized chronic disease data management in South Asia
By IPP Bureau - January 14, 2022
Three Indian firms namely Curisin, Immunidex and Telemedicine Indian company are part of the first phase
AstraZeneca and Scorpian Therapeutics partner to target novel cancer treatments
By IPP Bureau - January 14, 2022
The new collaboration focuses on a class of proteins called transcription factors, which control gene expression and can regulate important cellular processes including cell growth and survival
South Korea approves Novavax Covid-19 vaccine
By IPP Bureau - January 13, 2022
Nuvaxovid is the first protein-based Covid-19 vaccine granted approval in South Korea
Metropolis Healthcare opens MedEngage Scholarship programme
By IPP Bureau - January 13, 2022
The last date to apply for this program is 18th January 2022
Normalised quarter with impending margin pressure: ICICI Direct
By IPP Bureau - January 13, 2022
ICICI Direct gives a preview on the earnings narrative for Q3FY22
Cipla wins Frost & Sullivan and Teri Sustainability award for `Challenger in Mega Large Business Pharma Sector’
By IPP Bureau - January 13, 2022
The companies were evaluated via a comprehensive, in-depth assessment process that included a sustainability framework of 300 points each for – Purpose, Partnership, Planet and People
